Literature DB >> 20980527

Thermal transition of native tobacco mosaic virus and RNA-free viral proteins into spherical nanoparticles.

Joseph Atabekov1, Nikolai Nikitin, Marina Arkhipenko, Sergey Chirkov, Olga Karpova.   

Abstract

Spherical nanoparticles (SNPs) were generated by two-step thermal remodelling of native tobacco mosaic virus (TMV) at 94 °C. Particles of irregular shape and varying size were generated by TMV at 90 °C. They could be converted into SNPs by heating at 94 °C and were considered to be intermediate precursors of SNPs. In addition to SNP monomers (53 nm diameter), generated by individual TMV virions, large SNPs (100-800 nm diameter) were assembled. The size of the SNPs depended on the TMV concentration. The SNPs could be generated by distinct forms of RNA-free TMV coat protein (CP) aggregates and individual CP subunits. A one-step SNP assembly appeared to occur in these cases. These results show that SNPs represent a new type of particle nanoplatform for producing compositions of SNPs with foreign protein molecules bound to their surface.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20980527     DOI: 10.1099/vir.0.024356-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  26 in total

1.  Photonics and plasmonics go viral: self-assembly of hierarchical metamaterials.

Authors:  Amy M Wen; Rudolf Podgornik; Giuseppe Strangi; Nicole F Steinmetz
Journal:  Rend Lincei Sci Fis Nat       Date:  2015-03-05       Impact factor: 1.627

2.  In Situ Vaccination with Cowpea vs Tobacco Mosaic Virus against Melanoma.

Authors:  Abner A Murray; Chao Wang; Steven Fiering; Nicole F Steinmetz
Journal:  Mol Pharm       Date:  2018-05-25       Impact factor: 4.939

Review 3.  Recombinant helical plant virus-based nanoparticles for vaccination and immunotherapy.

Authors:  Kannan Badri Narayanan; Sung Soo Han
Journal:  Virus Genes       Date:  2018-07-14       Impact factor: 2.332

4.  Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.

Authors:  Michael A Bruckman; Lauren N Randolph; Allen VanMeter; Stephen Hern; Andrew J Shoffstall; Rebecca E Taurog; Nicole F Steinmetz
Journal:  Virology       Date:  2013-12-05       Impact factor: 3.616

Review 5.  Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine.

Authors:  Sourabh Shukla; Nicole F Steinmetz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2015-02-12

6.  Two approaches for the stabilization of Bacillus anthracis recombinant protective antigen.

Authors:  Ekaterina M Ryabchevskaya; Ekaterina A Evtushenko; Dmitry L Granovskiy; Peter A Ivanov; Joseph G Atabekov; Olga A Kondakova; Nikolai A Nikitin; Olga V Karpova
Journal:  Hum Vaccin Immunother       Date:  2020-07-02       Impact factor: 3.452

7.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents.

Authors:  Michael A Bruckman; Stephen Hern; Kai Jiang; Chris A Flask; Xin Yu; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2013-03-14       Impact factor: 6.331

8.  Exceptionally stable, redox-active supramolecular protein assemblies with emergent properties.

Authors:  Jeffrey D Brodin; Jessica R Carr; Pamela A Sontz; F Akif Tezcan
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-10       Impact factor: 11.205

9.  Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.

Authors:  Michael A Bruckman; Anna E Czapar; Allen VanMeter; Lauren N Randolph; Nicole F Steinmetz
Journal:  J Control Release       Date:  2016-03-03       Impact factor: 9.776

10.  Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging.

Authors:  Amy M Wen; Yunmei Wang; Kai Jiang; Greg C Hsu; Huiyun Gao; Karin L Lee; Alice C Yang; Xin Yu; Daniel I Simon; Nicole F Steinmetz
Journal:  J Mater Chem B       Date:  2015-06-10       Impact factor: 6.331

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.